Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy

被引:89
作者
Ichinose, Kunihiro
Kawasaki, Eiji
Eguchi, Katsumi
机构
[1] Nagasaki Univ, Hosp Med & Dent, Dept Metab Diabet & Clin Nutr, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Rheumatol, Unit Transplantat Med, Nagasaki 852, Japan
关键词
type 1 diabetes mellitus; genetics; cytokines; angiogenesis; autoimmunity; inflammation; diabetic nephropathy; pathogenesis;
D O I
10.1159/000107758
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Type 1 diabetes mellitus is an autoimmune disease characterized by progressive destruction of pancreatic beta cells by genetic and environmental factors which leads to an absolute dependence of insulin for survival and maintenance of health. Although the majority of mechanisms of beta cell destruction remain unclear, many molecules, including proinflammatory cytokines and chemokines such as tumor necrosis factor alpha and monocyte chemoattractant protein-1, are implicated in the development of beta cell damage. Furthermore, beta cell destruction is enhanced by the Th1 and Th17 subsets of CD4+ T cells. In contrast, there are mechanisms involved in the maintenance of peripheral tolerance by regulatory T cells, the function of which depends on the pleiotropic cytokine transforming growth factor beta. Development and progression of renal injuries in patients with diabetic nephropathy are also associated with several growth factors and proinflammatory cytokines, including tumor necrosis factor alpha, insulin-like growth factor-1, monocyte chemoattractant protein-1, vascular endothelial growth factor, and transforming growth factor beta. Although the pathogenic mechanisms underlying type 1 diabetes and diabetic nephropathy are principally different, i.e., autoimmunity and inflammation, some common factors, including susceptibility genes and proinflammatory cytokines, are involved in both mechanisms, including infiltrating cell recruitment, upregulation of other cytokines and chemokines, or apoptosis. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:554 / 564
页数:11
相关论文
共 107 条
[1]   Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy [J].
Aaltonen, P ;
Luimula, P ;
Åström, E ;
Palmen, T ;
Grönholm, T ;
Palojoki, E ;
Jaakkola, I ;
Ahola, H ;
Tikkanen, I ;
Holthöfer, H .
LABORATORY INVESTIGATION, 2001, 81 (09) :1185-1190
[2]   The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease [J].
Afzali, B. ;
Lombardi, G. ;
Lechler, R. I. ;
Lord, G. M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (01) :32-46
[3]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[4]  
2-S
[5]  
ANDERSEN AR, 1983, DIABETOLOGIA, V25, P496
[6]   A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes [J].
Balasa, B ;
La Cava, A ;
Van Gunst, K ;
Mocnik, L ;
Balakrishna, D ;
Nguyen, N ;
Tucker, L ;
Sarvetnick, N .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :7330-7337
[7]   PROTEINURIA AND ACTIVATED LYMPHOCYTES-T IN DIABETIC NEPHROPATHY [J].
BENDING, JJ ;
LOBOYEO, A ;
VERGANI, D ;
VIBERTI, G .
DIABETES, 1988, 37 (05) :507-511
[8]   A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus [J].
Bohren, KM ;
Nadkarni, V ;
Song, JH ;
Gabbay, KH ;
Owerbach, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) :27233-27238
[9]   IS DIABETIC NEPHROPATHY AN INHERITED COMPLICATION [J].
BORCHJOHNSEN, K ;
NORGAARD, K ;
HOMMEL, E ;
MATHIESEN, ER ;
JENSEN, JS ;
DECKERT, T ;
PARVING, HH .
KIDNEY INTERNATIONAL, 1992, 41 (04) :719-722
[10]   Elevated levels of mannose-binding lectin at clinical manifestation of type 1 diabetes in juveniles [J].
Bouwman, LH ;
Eerligh, P ;
Terpstra, OT ;
Daha, MR ;
de Knijff, P ;
Ballieux, BEPB ;
Bruining, GJ ;
van der Slik, AR ;
Roos, A ;
Roep, BO .
DIABETES, 2005, 54 (10) :3002-3006